A detailed history of Polar Capital Holdings PLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Polar Capital Holdings PLC holds 1,831,000 shares of YMAB stock, worth $14.8 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,831,000
Previous 1,831,000 -0.0%
Holding current value
$14.8 Million
Previous $22.1 Million 8.69%
% of portfolio
0.15%
Previous 0.13%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$6.57 - $18.69 $1.48 Million - $4.22 Million
-225,872 Reduced 10.98%
1,831,000 $29.8 Million
Q4 2023

Feb 14, 2024

SELL
$4.88 - $7.42 $226,558 - $344,480
-46,426 Reduced 2.21%
2,056,872 $14 Million
Q2 2023

Dec 13, 2023

BUY
$5.68 - $10.34 $632,575 - $1.15 Million
111,369 Added 5.59%
2,103,298 $14.3 Million
Q2 2023

Aug 14, 2023

BUY
$5.68 - $10.34 $632,575 - $1.15 Million
111,369 Added 5.59%
2,103,298 $14.3 Million
Q1 2023

Dec 13, 2023

SELL
$2.83 - $5.11 $315,174 - $569,095
-111,369 Reduced 5.29%
1,991,929 $9.98 Million
Q4 2022

Feb 14, 2023

SELL
$3.0 - $15.17 $1.62 Million - $8.19 Million
-539,617 Reduced 21.32%
1,991,929 $9.72 Million
Q3 2022

Nov 14, 2022

SELL
$13.96 - $19.67 $5.88 Million - $8.28 Million
-421,125 Reduced 14.26%
2,531,546 $36.5 Million
Q2 2022

Aug 15, 2022

BUY
$8.22 - $15.13 $616,500 - $1.13 Million
75,000 Added 2.61%
2,952,671 $44.7 Million
Q1 2022

May 16, 2022

BUY
$6.55 - $17.42 $9.83 Million - $26.1 Million
1,500,000 Added 108.88%
2,877,671 $34.2 Million
Q4 2021

Feb 14, 2022

BUY
$15.51 - $29.31 $3.45 Million - $6.53 Million
222,710 Added 19.28%
1,377,671 $22.3 Million
Q3 2021

Nov 15, 2021

BUY
$27.47 - $37.31 $15.6 Million - $21.2 Million
569,040 Added 97.12%
1,154,961 $33 Million
Q2 2021

Aug 16, 2021

BUY
$25.45 - $37.64 $14.7 Million - $21.8 Million
577,892 Added 7197.56%
585,921 $19.8 Million
Q1 2021

May 17, 2021

SELL
$29.16 - $51.96 $14.6 Million - $26 Million
-499,604 Reduced 98.42%
8,029 $243,000
Q4 2020

Feb 16, 2021

BUY
$37.86 - $54.26 $19.2 Million - $27.5 Million
507,633 New
507,633 $25.1 Million

Others Institutions Holding YMAB

About Y-mAbs Therapeutics, Inc.


  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $355M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track Polar Capital Holdings PLC Portfolio

Follow Polar Capital Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.